United States: In a new study represented that a large number of women are unaware of a basic symptoms that represent endometrial cancer, a common cancer affecting the female reproductive organs.
More about the finding
The survey revealed that as many as 37 percent of women respondents neither knew nor could identify that postmenopausal bleeding is one of the indicators of endometrial cancer said the researchers.
Worse, only 41 percent of the respondents said that they would not report postmenopausal bleeding to their doctor if they’d only had one episode.
In such a case, it may be because doctors do not adequately counsel women, as the results demonstrated in the US News report.
As per Dr. Meredith Wise, the lead of the research team and an assistant professor of obstetrics and gynecology at the University of Minnesota Medical School, “There is a need for increased recognition of postmenopausal bleeding and provider counseling on postmenopausal bleeding, and educational interventions should focus on public and provider awareness of endometrial cancer risks and symptoms,” as the US News reported.
More about the endometrium cancer
Endometrium as a spawning cancer initiates when cells of the endometrial lining of the uterus start to proliferate uncontrolled, as defined by the American Cancer Society.
Based on ACS calculations, around seventy thousand new cases of uterine cancer will be identified this year, and almost 15,000 women are anticipated to die from uterine cancer.
Uterine cancer has been rising more than 2 percent every year in the United States partly because of escalating obesity in the population, researchers unveiled. Mortality figures also rose by more than 1 percent per year between 1999 and 2016.
Currently, there is no screening test for endometrial cancer. However, most cases are diagnosed at an early stage because this type of cancer has symptoms like abnormal and post менопаузal bleeding, the scientists added.
If detected early, endometrial cancer can be treated, and the five-year survival rate is nearly 95 percent, according to researchers. However, the mortality rate concerning the progressed condition when the cancer has spread is below 19 percent.
Thus, the concern was conducted with 648 women exposed to the survey in September 2021 at the Minnesota State Fair. Researchers added that 145 of them had gone through menopause.
According to Dr. Stephanie Faubion, medical director for The Menopause Society, “This survey study highlights opportunities for improved patient counseling about abnormal and postmenopausal uterine bleeding as an early warning sign of uterine cancer. This is especially important given that the incidence and mortality rates of uterine cancer continue to increase and are notably highest in women of color,” as the US News reported.